SCHEMBL7700905

SCHEMBL7700905

CC(C)(C/C=C/C(O)(C(F)(F)F)C(F)(F)F)CCCC=O

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACLY P53396 1/20 0.32
FAAH O00519 2/20 0.32
TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651471 1.00 ACLY (0.32) ACLYFAAHTRPV1
SCHEMBL6651466 1.00 ACLY (0.32) ACLYFAAHTRPV1
SCHEMBL14489225 0.83 FAAH (0.33) ACLYFAAHTRPV1
SCHEMBL7697578 0.83 FAAH (0.35) ACLYFAAHTRPV1
SCHEMBL7697580 0.83 FAAH (0.35) ACLYFAAHTRPV1
SCHEMBL7701604 0.80
SCHEMBL7698667 0.78
SCHEMBL7698672 0.78
SCHEMBL7701671 0.78
SCHEMBL6651139 0.75 MLYCD (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed